BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 18078933)

  • 1. Pericytes and ocular diseases.
    Motiejūnaite R; Kazlauskas A
    Exp Eye Res; 2008 Feb; 86(2):171-7. PubMed ID: 18078933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy.
    Hall AP
    Toxicol Pathol; 2006; 34(6):763-75. PubMed ID: 17162534
    [No Abstract]   [Full Text] [Related]  

  • 3. [Angiogenesis in ophthalmology. A theme with a future].
    Joussen AM; Kirchhof B
    Ophthalmologe; 2003 Apr; 100(4):281-3. PubMed ID: 12723577
    [No Abstract]   [Full Text] [Related]  

  • 4. Pericytes and vessel maturation during tumor angiogenesis and metastasis.
    Raza A; Franklin MJ; Dudek AZ
    Am J Hematol; 2010 Aug; 85(8):593-8. PubMed ID: 20540157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinopathy of prematurity. Pathologic correlation of clinical stages.
    Foos RY
    Retina; 1987; 7(4):260-76. PubMed ID: 2448856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular mechanisms of vasculogenesis and angiogenesis. What regulates vascular growth?].
    Joussen AM; Kirchhof B; Gottstein C
    Ophthalmologe; 2003 Apr; 100(4):284-91. PubMed ID: 12682760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenic interaction between retinal endothelial cells and pericytes from normal and diabetic rabbits, and phenotypic changes of diabetic cells.
    Morisaki N; Watanabe S; Fukuda K; Saito Y
    Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):67-77. PubMed ID: 10099841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal and choroidal microangiopathies: therapeutic opportunities.
    Afzal A; Shaw LC; Ljubimov AV; Boulton ME; Segal MS; Grant MB
    Microvasc Res; 2007; 74(2-3):131-44. PubMed ID: 17585951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy.
    Zhang SX; Ma JX
    Prog Retin Eye Res; 2007 Jan; 26(1):1-37. PubMed ID: 17074526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in pericytes and smooth muscle cells in the kitten model of retinopathy of prematurity: implications for plus disease.
    Hughes S; Gardiner T; Baxter L; Chan-Ling T
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1368-79. PubMed ID: 17325186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoinhibins: novel inhibitors of ocular angiogenesis.
    Clapp C; Thebault S; Arnold E; García C; Rivera JC; de la Escalera GM
    Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E772-8. PubMed ID: 18544641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on retinal neovascularization. Friedenwald Lecture.
    Patz A
    Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1133-8. PubMed ID: 6158493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retinal vascular lesions in diabetic retinopathy].
    Crăiţoiu S; Mocanu C; Olaru C; Rodica M
    Oftalmologia; 2005; 49(1):82-7. PubMed ID: 15934345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of the ocular angiogenesis animal models.
    Montezuma SR; Vavvas D; Miller JW
    Semin Ophthalmol; 2009; 24(2):52-61. PubMed ID: 19373687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy.
    Cai J; Kehoe O; Smith GM; Hykin P; Boulton ME
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):2163-71. PubMed ID: 18436850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Special features of human retinal angiogenesis.
    Gariano RF
    Eye (Lond); 2010 Mar; 24(3):401-7. PubMed ID: 20075971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proliferative retinopathy in experimental studies].
    Prost M
    Klin Oczna; 1985 Dec; 87(12):486-8. PubMed ID: 2423744
    [No Abstract]   [Full Text] [Related]  

  • 18. Rosmarinic acid suppresses retinal neovascularization via cell cycle arrest with increase of p21(WAF1) expression.
    Kim JH; Lee BJ; Kim JH; Yu YS; Kim MY; Kim KW
    Eur J Pharmacol; 2009 Aug; 615(1-3):150-4. PubMed ID: 19470386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factors influencing ocular angiogenesis].
    Neroev VV; Sarygina OI; Levkina OA
    Vestn Oftalmol; 2009; 125(3):52-5. PubMed ID: 19566051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential future targets for treating ocular neovascularization.
    Barouch FC; Miller JW
    Ophthalmol Clin North Am; 2006 Sep; 19(3):401-9. PubMed ID: 16935215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.